You just read:

Entest BioMedical's Subsidiary Zander Therapeutics, Inc., Reports Its Series A Compounds Suppressed the Production of Multiple Cytokines Known to be Involved in Inflammation With No Toxicity In Canine Studies

News provided by

Entest BioMedical Inc.

Jun 13, 2017, 16:00 ET